WallStreetZenWallStreetZen

NASDAQ: IOBT
Io Biotech Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IOBT

Based on 2 analysts offering 12 month price targets for Io Biotech Inc

Min Forecast
$3.00+232.59%
Avg Forecast
$3.50+288.03%
Max Forecast
$4.00+343.46%

Should I buy or sell IOBT stock?

Based on 2 analysts offering ratings for Io Biotech Inc.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although IOBT's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates IOBT as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their IOBT stock forecasts and price targets.

IOBT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-22
lockedlocked$00.00+00.00%2025-08-12

1 of 1

Forecast return on equity

Is IOBT forecast to generate an efficient return?

Company
N/A
Industry
285.59%
Market
231.17%

Forecast return on assets

Is IOBT forecast to generate an efficient return on assets?

Company
N/A
Industry
96.56%

IOBT earnings per share forecast

What is IOBT's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$1.34
Avg 2 year Forecast
-$0.58
Avg 3 year Forecast
-$0.62

IOBT revenue forecast

What is IOBT's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$11.0M
Avg 3 year Forecast
$39.7M

IOBT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IOBT$0.90$3.50+288.03%Strong Buy
ACRV$1.88$8.00+325.53%Buy
OSTX$1.84$20.00+986.96%Strong Buy
CRVO$6.92$22.80+229.48%Strong Buy
INKT$12.81$35.00+173.22%Buy
View Top Biotech Stocks

Io Biotech Stock Forecast FAQ

Is Io Biotech Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: IOBT) stock is to Strong Buy IOBT stock.

Out of 2 analysts, 2 (100%) are recommending IOBT as a Strong Buy, 0 (0%) are recommending IOBT as a Buy, 0 (0%) are recommending IOBT as a Hold, 0 (0%) are recommending IOBT as a Sell, and 0 (0%) are recommending IOBT as a Strong Sell.

If you're new to stock investing, here's how to buy Io Biotech stock.

What is IOBT's earnings growth forecast for 2025-2027?

(NASDAQ: IOBT) Io Biotech's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 47.92%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.93%.

Io Biotech's earnings in 2025 is -$103,986,000.On average, 7 Wall Street analysts forecast IOBT's earnings for 2025 to be -$88,366,070, with the lowest IOBT earnings forecast at -$97,490,577, and the highest IOBT earnings forecast at -$83,009,952. On average, 7 Wall Street analysts forecast IOBT's earnings for 2026 to be -$38,033,052, with the lowest IOBT earnings forecast at -$53,587,535, and the highest IOBT earnings forecast at -$12,451,493.

In 2027, IOBT is forecast to generate -$40,720,993 in earnings, with the lowest earnings forecast at -$50,359,371 and the highest earnings forecast at -$20,752,488.

What is IOBT's revenue growth forecast for 2025-2027?

(NASDAQ: IOBT) Io Biotech's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 109.05%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.77%.

Io Biotech's revenue in 2025 is $0.On average, 7 Wall Street analysts forecast IOBT's revenue for 2025 to be $0, with the lowest IOBT revenue forecast at $0, and the highest IOBT revenue forecast at $0. On average, 8 Wall Street analysts forecast IOBT's revenue for 2026 to be $726,139,434, with the lowest IOBT revenue forecast at $0, and the highest IOBT revenue forecast at $2,054,628,065.

In 2027, IOBT is forecast to generate $2,618,173,403 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $5,351,374,882.

What is IOBT's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: IOBT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 96.56%.

What is IOBT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year IOBT price target, the average IOBT price target is $3.50, with the highest IOBT stock price forecast at $4.00 and the lowest IOBT stock price forecast at $3.00.

On average, Wall Street analysts predict that Io Biotech's share price could reach $3.50 by Oct 22, 2026. The average Io Biotech stock price prediction forecasts a potential upside of 288.03% from the current IOBT share price of $0.90.

What is IOBT's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: IOBT) Io Biotech's current Earnings Per Share (EPS) is -$1.58. On average, analysts forecast that IOBT's EPS will be -$1.34 for 2025, with the lowest EPS forecast at -$1.48, and the highest EPS forecast at -$1.26. On average, analysts forecast that IOBT's EPS will be -$0.58 for 2026, with the lowest EPS forecast at -$0.81, and the highest EPS forecast at -$0.19. In 2027, IOBT's EPS is forecast to hit -$0.62 (min: -$0.76, max: -$0.32).

What is IOBT's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: IOBT) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.